Glioblastoma WHO IV NCH89 cell line

NCH89 is a patient-derived IDH wildtype glioblastoma cell line established from a primary WHO grade IV tumour obtained from a 41 year old female patient. Cells grow as adherent monolayer…

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.